What Does the Future Hold for XRP? Key Levels Revealed

Cryptocurrency analytics company MakroVision has shared its latest technical assessment of $XRP. The company stated that $XRP is currently trading within a significant price range and is once again approaching a critical resistance level.

According to MacroVision, $XRP has shown signs of recovery after the recent pullback, moving upwards again within a significant short-term price range. The $1.54 level is particularly noteworthy, being described as a critical threshold for the market.

Looking at the technical structure, it was noted that the overall outlook has not yet fully gained strength. $XRP is still trading below significant resistance levels, and therefore exhibits a weak performance in the long term. However, the short-term price movement could be interpreted as an attempt to form a bottom after a sharp decline. According to the analysis, the range between $1.32 and $1.55 is currently the decisive factor.

MacroVision identified the $1.32 level as a critical support against downside risks. It stated that if $XRP manages to stay above this level, the current stabilization process could continue, but warned that a break above this level could lead to renewed selling pressure.

In the upward scenario, the $1.55 level stands out as the first significant resistance. A strong break above this level would increase the likelihood of the price moving towards the $1.82 region. Analysts argue that for the medium-term outlook to turn positive again, this upper band must also be broken.

MakroVision, noting that the most critical development in the upcoming period will occur at the $1.55 level, stated that a clear break above this level could initiate a stronger recovery in $XRP. Conversely, it was stated that if the price is rejected again from this region, downward pressure could rapidly increase. Furthermore, it was noted that if $XRP closes below $1.32 for two consecutive days, the current recovery scenario could become invalid, and lower levels could be retested.

*This is not investment advice.